NCI Starts SBIR Regulatory Help Effort

NCI expects its new Regulatory Assistance Program to provide guidance as some SBIR firms chart their course toward FDA approval.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.